To assess the biological significance of activating mTOR in PNI of pancreatic cancer, MHY-1485 (mTOR activator that targets the ATP domain of mTOR) was used to treat pancreatic cancer cells. This evidence concerns the gene MTOR and familial pancreatic carcinoma.